Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002. That is: it failed.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/09/26/axovant-raised-hundreds-of-millions-around-its-alzheimers-drug-it-just-failed/
via IFTTT
No comments:
Post a Comment